LONSURF (trifluridine and tipiracil) tablets
LONSURF is a combination of trifluridine, a nucleoside metabolic inhibitor,and tipiracil, a thymidine phosphorylase inhibitor, indicated for the treatment of patients with metastatic colorectal cancer. Brand Name: LONSURF (trifluridine and tipiracil) tablets, for oral use Initial U.S. Approval: 2015
Home | (trifluridine and tipiracil) tablets
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient inquires under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
LONSURF (trifluridine and tipiracil) tablets
Trifluridine and tipiracil hydrochloride is approved to treat adults with: Colorectal cancer, Stomach adenocarcinoma or gastroesophageal junction adenocarcinoma (a rare type of esophageal cancer). Trifluridine and tipiracil hydrochloride is also being studied in the treatment of other types of cancer.
Lonsurf is a medicine used to treat adults with colorectal cancer (cancer of the large bowel) and gastric (stomach) cancer. It is used when the cancer is metastatic (has spread to other parts of the body) in patients who have already been treated with, or who cannot be given, other treatments for their cancer.
A combination of two drugs used to treat adults with certain types of stomach cancer, gastroesophageal junction cancer, or colorectal cancer. It is used in patients whose cancer has spread to other parts of the body and has already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Lonsurf stops cells from making DNA, which may help keep cancer cells from growing and may kill them. It is a type of antimetabolite and a type of thymidine phosphorylase inhibitor. Also called trifluridine and tipiracil hydrochloride.
Trifluridine/tipiracil (FTD–TPI), is a fixed-dose combination medication that is used as a third- or fourth-line treatment of metastatic colorectal cancer or gastric cancer, after chemotherapy and targeted therapeutics have failed. It is a combination of two active pharmaceutical ingredients: trifluridine, a nucleoside analog, and tipiracil, a thymidine phosphorylase inhibitor. Tipiracil prevents rapid metabolism of trifluridine, increasing the bioavailability of trifluridine.
Drug (Brand / Generic): LONSURF / trifluridine and tipiracil
Current Indications: colorectal cancer (cancer of the large bowel) and gastric (stomach) cancer.
Marketed by:: Taiho Oncology, Inc.
Approval Date: 2015
Dosage forms and strengths of LONSURF (trifluridine and tipiracil).
• 15 mg trifluridine/6.14 mg tipiracil
• 20 mg trifluridine/8.19 mg tipiracil
Find Reference Updates
Alleviare Life Sciences
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “LONSURF (trifluridine and tipiracil) tablets”.
Confirmation of the order for LONSURF (trifluridine and tipiracil) tablets will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand LONSURF (trifluridine and tipiracil) tablets. The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to LONSURF (trifluridine and tipiracil) tablets, they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
Kindly reach out to us for LONSURF (trifluridine and tipiracil) tablets price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.